Skip to main content
. 2022 Sep 13;12(9):e1046. doi: 10.1002/ctm2.1046

TABLE 1.

Complete blood count (CBC) analysis. (A) Whole blood CBC analysis in C57BL/6J mice 8 weeks post‐transplantation of 360k human neural stem cell (hNSC)‐luc+/green fluorescent protein (GFP)+. CBC panel measures and data (mean ± standard deviation) for each experimental group. (B) CBC measures were compared between groups, and statistically significant comparisons are highlighted

A. CBC results
Measure Normal range

No IS

(n = 7)

Tac

(n = 6)

Tac mAb

(n = 7)

mAb

(n = 7)

White blood cell count ‐ WBC (10 3 /μl) 1.8–10.7 3.123 ± .5019 1.007 ± .5417 1.194 ± .7348 3.28 ± 1.469
Neutrophil count ‐ NE (10 3 /μl) .1–2.4 .8957 ± .5754 .2067 ± .1122 .2643 ± .1295 .6986 ± .3076
Lymphocyte count ‐ LY (10 3 /μl) .9–9.3 2.119 ± .4143 .755 ± .4117 .8714 ± .5934 2.471 ± 1.165
Monocyte count ‐ MO (10 3 /μl) .0–.4 .09143 ± .02545 .03 ± .0228 .04429 ± .02637 .09429 ± .07829
Eosinophil count ‐ EO (10 3 /μl) .0–.2 .01 ± .005774 .008333 ± .007528 .008571 ± .006901 .01429 ± .01272
Basophil count ‐ BA (10 3 /μl) .0–.2 .004286 ± .005345 .003333 ± .008165 .004286 ± .005345 .002857 ± .00488
Red blood cell count ‐ RBC (10 6 /μl) 6.36–9.42 8.579 ± .31 8.478 ± .8597 9.18 ± .7665 9.134 ± .4404
Hemoglobin ‐ HB (g/dl) 11.0–15.1 11.69 ± .3891 10.97 ± 1.234 11.91 ± .4634 11.73 ± .6317
Hematocrit ‐ HCT (%) 35.1–45.4 37.01 ± 1.471 35.63 ± 3.976 38.17 ± 1.608 39.47 ± 2.391
Mean cell volume ‐ MCV (fL) 45.4–60.3 43.14 ± .5442 42 ± .6663 41.71 ± 1.875 43.2 ± .8794
Mean cell hemoglobin ‐ MCH (pg) 14.1–19.3 13.64 ± .1902 12.9 ± .2098 13.01 ± .7151 12.83 ± .4751
MCH concentrate ‐ MCHC (g/dl) 30.2–34.2 31.59 ± .3805 30.78 ± .4167 31.21 ± 1.014 29.73 ± .9759
Red cell distribution width ‐ RDW (%) 12.4–27.0 17.74 ± .4894 17.18 ± .7305 18.24 ± 1.247 18.04 ± .4036
Platelet count ‐PLT (10 3 /μl) 592—2972 439.9 ± 197.1 377.3 ± 250.2 472.3 ± 249.2 662.3 ± 105.1
Mean platelet volume ‐ MPV (fL) 5.0–20.0 4.543 ± .4198 4.717 ± .6401 4.514 ± .7988 4.271 ± .1799
B. CBC statistics
Group comparison WBC NE LY MO EO BA RBC
No IS versus Tac **** *** *** * ns ns ns
No IS versus Tac MAb *** *** ** * ns ns ns
No IS versus MAb ns ns ns ns ns ns ns
Tac versus Tac MAb ns ns ns ns Ns ns *
Tac versus MAb **** ** **** ** Ns ns ns
Tac MAb versus MAb **** * **** * Ns ns ns
*

Significant (p < .0332) by one‐way ANOVA.

**

Significant (p < .0021) by one‐way ANOVA.

***

Significant (p < .0001) by one‐way ANOVA.